Jove
Visualize
Contact Us

Related Experiment Videos

Probiotics in gastroenterology.

Paolo Gionchetti1, Fernando Rizzello, Massimo Campieri

  • 1Center for Inflammatory Bowel Disease, Department of Internal Medicine, University of Bologna, Italy. paolo@med.unibo.it

Current Opinion in Gastroenterology
|October 13, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and safety of mirikizumab in multirefractory ulcerative colitis: analysis from a real-world cohort.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·2026
Same author

Pan-enteric Capsule Endoscopy in Crohn's Disease: Impact on Therapeutic Decisions and Inter-observer Agreement in a Multicentre Case-based Study.

Endoscopy international open·2026
Same author

Corrigendum to 'Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care' [Autoimmunity Reviews 25 (2026) 104068].

Autoimmunity reviews·2026
Same author

Long-Term Outcomes of Mediterranean-Adapted Crohn's Disease Exclusion Diet in Mild Pediatric Crohn's Disease: A Real-Life Study from a Referral IBD Center.

Nutrients·2026
Same author

Dynamic profiling in inflammatory Bowel disease: A manifesto for personalized care.

Autoimmunity reviews·2026
Same author

Multicenter Real-World Outcomes of Risankizumab in Crohn's Disease: The RESOLVE IG-IBD Study.

The American journal of gastroenterology·2026
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Probiotics show therapeutic potential for various gastrointestinal diseases, including infections and inflammatory bowel disease. Further research is needed to confirm mechanisms and optimize probiotic strain selection for clinical trials.

Area of Science:

  • Gastroenterology
  • Microbiology
  • Pharmacology

Background:

  • Emerging evidence suggests probiotics may play a therapeutic role in gastrointestinal diseases.
  • Probiotics have demonstrated benefits in managing infectious diarrhea, including viral, Clostridium difficile-associated, traveler's, and antibiotic-associated diarrhea.

Purpose of the Study:

  • To review the current evidence on the therapeutic applications of probiotics in gastrointestinal disorders.
  • To highlight the need for well-characterized probiotic preparations and further research into their mechanisms of action.

Main Methods:

  • Literature review of studies investigating probiotic efficacy in gastrointestinal conditions.
  • Analysis of data supporting probiotic use in infections, inflammatory bowel disease, Helicobacter pylori infection, irritable bowel syndrome, and radiotherapy-associated diarrhea.

Related Experiment Videos

Main Results:

  • Probiotics show promise in treating various forms of diarrhea and may benefit inflammatory bowel disease.
  • Potential applications extend to Helicobacter pylori infection, irritable bowel syndrome, and radiotherapy-associated diarrhea.

Conclusions:

  • Well-characterized probiotic preparations are crucial for therapeutic success.
  • Further research into the in vivo mechanisms of probiotic action is necessary to guide the development of large-scale clinical trials.